Zentalis Pharmaceuticals, Inc. (ZNTL) - Quarterly Income Statement

Home
ZNTL
Financials

2.78 (USD) • At close January 8, 2025

Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

	2024 Q3	2024 Q2	2024 Q1	2023 Q4	2023 Q3	2023 Q2	2023 Q1	2022 Q4	2022 Q3	2022 Q2	2022 Q1	2021 Q4	2021 Q3	2021 Q2	2021 Q1	2020 Q4	2020 Q3	2020 Q2	2020 Q1	2019 Q4	2019 Q3	2019 Q2	2019 Q1
Revenue Numbers are in millions	0	0	40.56	2.104	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cost of Revenue Numbers are in millions	0	0.327	0.324	0.337	0.348	0.344	0.36	0.359	0.375	0.348	0.344	0.209	0.137	0.119	0.079	0	0	0	0	0	0	0	0
Gross Profit Numbers are in millions	0	-0.327	40.236	1.767	-0.348	-0.344	-0.36	-0.359	-0.375	-0.348	-0.344	-0.209	-0.137	-0.119	-0.079	0	0	0	0	0	0	0	0
Gross Profit Ratio Numbers are in millions	0	0	0.992	0.84	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Reseach & Development Expenses Numbers are in millions	36.824	48.386	49.585	51.557	46.765	42.684	48.584	40.616	42.181	43.825	46.112	38.439	53.998	44.77	38.394	29.521	24.67	17.452	13.258	11.869	10.739	8.689	7.089
General & Administrative Expenses Numbers are in millions	14.608	16.762	15.74	16.365	15.953	15.664	16.369	11.138	12.012	19.636	11.767	9.754	8.872	10.362	11.953	10.724	10.097	9.924	3.141	3.036	1.844	1.946	1.633
Selling & Marketing Expenses Numbers are in millions	0	0	-0.324	-0.337	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
SG&A Numbers are in millions	14.608	16.762	15.416	16.028	15.953	15.664	16.369	11.138	12.012	19.636	11.767	9.754	8.872	10.362	11.953	10.724	10.097	9.924	3.141	3.036	1.844	1.946	1.633
Other Expenses Numbers are in millions	0	0	0	0	0	45.568	0	0	0	0	0	0	0	0	-0.044	0	0	0	0	0	0	0	-0.012
Operating Expenses Numbers are in millions	51.432	65.148	65.001	67.585	62.718	58.348	64.953	51.754	54.193	63.461	57.879	48.193	62.87	55.132	50.347	40.245	34.767	27.376	16.399	14.905	12.583	10.635	8.722
Operating Income Numbers are in millions	-51.432	-65.148	-24.765	-67.922	-62.718	-103.916	-64.953	-51.754	-54.193	-63.461	-57.879	-48.193	-62.87	-55.132	-50.347	-40.245	-34.767	-27.376	-16.399	-14.905	-12.583	-10.635	-8.722
Operating Income Ratio Numbers are in millions	0	0	-0.611	-32.282	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Other Income Expenses Net Numbers are in millions	11.247	-22.863	34.948	6.848	7.209	-41.117	4.109	3.232	1.905	0.424	0.426	0.088	51.681	0.115	0.099	0.315	0.12	0.084	0.164	0.359	0.012	0.049	0.062
Income Before Tax Numbers are in millions	-40.185	-88.011	10.183	-61.074	-55.509	-99.465	-60.844	-48.522	-52.288	-63.037	-57.453	-48.105	-11.189	-55.017	-50.248	-39.93	-34.647	-27.292	-16.235	-14.546	-12.571	-10.586	-8.66
Income Before Tax Ratio Numbers are in millions	0	0	0.251	-29.028	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Income Tax Expense Numbers are in millions	-0.027	0.266	0.143	-0.135	0.031	-0.605	0.108	-0.36	-0.159	0.017	0.033	0.159	-0.697	0.045	0.196	0.426	0.018	-0.435	-0.109	-0.538	0.001	0.011	0.003
Net Income Numbers are in millions	-40.158	-88.277	10.068	-60.917	-55.528	-112.527	-60.952	-48.162	-52.129	-63.054	-57.486	-50.059	-4.191	-54.574	-49.901	-40.303	-34.555	-26.857	-16.126	-14.506	-12.344	-10.47	-8.343
Net Income Ratio Numbers are in millions	0	0	0.248	-28.953	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS Numbers are in millions	-0.56	-1.24	0.14	-0.86	-0.79	-1.85	-1.03	-0.81	-0.92	-1.23	-1.27	-1.11	-0.094	-1.34	-1.24	-1.01	-0.91	-0.78	-0.47	-0.44	-0.68	-0.58	-0.46
EPS Diluted Numbers are in millions	-0.56	-1.24	0.14	-0.86	-0.79	-1.85	-1.03	-0.81	-0.92	-1.23	-1.27	-1.11	-0.094	-1.34	-1.24	-1.01	-0.91	-0.78	-0.47	-0.42	-0.68	-0.58	-0.46
EBITDA Numbers are in millions	-51.111	-65.148	-24.441	-67.585	-62.37	-58.004	-64.593	-51.395	-53.818	-63.113	-57.535	-47.896	-62.733	-55.013	-50.268	-40.212	-34.716	-27.338	-16.361	-14.864	-12.558	-10.611	-8.701
EBITDA Ratio Numbers are in millions	0	0	-0.603	-32.122	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Zentalis Pharmaceuticals, Inc.

NASDAQ:ZNTL Add to watchlist

NASDAQ:ZNTL